Rights and permissions
About this article
Cite this article
Transgenic antithrombin III reduces the need for fresh frozen plasma in patients with heparin resistance who are undergoing elective heart surgery which requires cardiopulmonary bypass. Inpharma Wkly. 1220, 10 (2000). https://doi.org/10.2165/00128413-200012200-00022
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200012200-00022